almagate has been researched along with Myopia, Degenerative in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitagawa, T; Yuzawa, M | 1 |
Akagi-Kurashige, Y; Kumagai, K; Matsuda, F; Miyake, M; Nakanishi, H; Nakata, I; Oishi, A; Tsujikawa, A; Yamada, R; Yamashiro, K; Yoshimura, N | 1 |
Chiosi, F; Costagliola, C; DellʼOmo, R; Menzione, M; Parmeggiani, F; Rinaldi, M; Romano, MR; Semeraro, F | 1 |
Bennett, MD; Yee, W | 1 |
2 trial(s) available for almagate and Myopia, Degenerative
Article | Year |
---|---|
[Intravitreal pegaptanib sodium for myopic choroidal neovascularization: 1 year results of a prospective pilot study].
Topics: Adult; Aged; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Humans; Male; Middle Aged; Myopia, Degenerative; Pilot Projects; Prospective Studies; Retinal Vessels; Treatment Outcome | 2013 |
Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fovea Centralis; Humans; Intravitreal Injections; Male; Middle Aged; Myopia, Degenerative; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Field Tests; Visual Fields | 2013 |
2 other study(ies) available for almagate and Myopia, Degenerative
Article | Year |
---|---|
Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Axial Length, Eye; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Genotype; Humans; Male; Middle Aged; Myopia, Degenerative; Ophthalmoscopy; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Pegaptanib for myopic choroidal neovascularization in a young patient.
Topics: Adult; Angiogenesis Inhibitors; Aptamers, Nucleotide; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Myopia, Degenerative; Prognosis; Vascular Endothelial Growth Factor A; Visual Acuity | 2007 |